Latest Articles
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial - geneonline.com
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial geneonline.com
Published: Dec. 21, 2025, 12:34 p.m.
Brian Slomovitz: New Study on PARP Therapy Advances in Endometrial Cancer - Oncodaily
Brian Slomovitz: New Study on PARP Therapy Advances in Endometrial Cancer Oncodaily
Published: Dec. 19, 2025, 7:56 p.m.
Immunotherapy in Endometrial Cancer: Mechanisms, Clinical Evidence, and Future Directions - Frontiers
Immunotherapy in Endometrial Cancer: Mechanisms, Clinical Evidence, and Future Directions Frontiers
Published: Dec. 17, 2025, 5:24 p.m.
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Therapy for Advanced Endometrial Cancer - Cancer Nursing Today
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Therapy for Advanced Endometrial Cancer Cancer Nursing Today
Published: Dec. 15, 2025, 8:24 p.m.
The Impact of Hormone Replacement Therapy on Endometrial Pathology: A Retrospective Observational Study - Cureus
The Impact of Hormone Replacement Therapy on Endometrial Pathology: A Retrospective Observational Study Cureus
Published: Dec. 4, 2025, 4:59 a.m.
GSK’s Jemperli now standard in endometrial cancer as reimbursement expands to 1st-line therapy - koreabiomed.com
GSK’s Jemperli now standard in endometrial cancer as reimbursement expands to 1st-line therapy koreabiomed.com
Published: Dec. 1, 2025, 6:49 a.m.
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer - NAVLIN DAILY
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer NAVLIN DAILY
Published: Nov. 25, 2025, 2:06 p.m.
ASTRO releases new radiation therapy guidelines for gastric cancers - Radiology Business
ASTRO releases new radiation therapy guidelines for gastric cancers Radiology Business
Published: Nov. 19, 2025, 7:35 p.m.
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy - Endocrine Society
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy Endocrine Society
Published: Nov. 18, 2025, 9:22 a.m.
Mathematical model of optimal control for endometrial cancer with treatments dostarlimab and chemotherapy using Caputo derivative - Nature
Mathematical model of optimal control for endometrial cancer with treatments dostarlimab and chemotherapy using Caputo derivative Nature
Published: Nov. 11, 2025, 8:42 p.m.
Link copied to clipboard!